Table 1 Morphometric parameters of 18-day-old chicken embryos following in Ovo administration of Quercetin (Q10, Q100), hydroxyapatite (HaP10, HaP100), and their composites (QHaP10, QHaP100).

From: Biocompatibility and antioxidant effects of hydroxyapatite-quercetin composites: in vitro and in ovo studies

Parameter

Group

P value

CON

Q10

Q100

HaP10

HaP100

QHaP10

QHaP100

Mortality (%)

13.34

10.00

13.34

6.67

10.00

13.34

10.00

Egg weight (g)

51.16 ± 8.85

55.68 ± 10.12

59.05 ± 11.10

54.64 ± 11.99

58.61 ± 7.15

54.99 ± 7.89

54.55 ± 10.08

0.606

Embryo weight (g)

20.79 ± 2.91

22.32 ± 3.69

20.64 ± 2.20

20.44 ± 3.14

21.41 ± 2.10

23.22 ± 3.19

20.86 ± 4.28

0.398

Embryo-to-egg ratio (%)

41.73 ± 9.93

40.85 ± 8.06

36.48 ± 9.55

39.40 ± 12.36

36.99 ± 5.82

42.85 ± 7.37

39.70 ± 11.70

0.721

Liver (% of embryo weight)

2.04 ± 0.28B

1.89 ± 0.33B

1.84 ± 0.27B

1.28 ± 0.39A

2.03 ± 0.31B

1.71 ± 0.28B

1.92 ± 0.25B

< 0.001

Heart (% of embryo weight)

0.89 ± 0.16A

0.86 ± 0.15A

0.88 ± 0.15A

1.48 ± 0.32B

0.92 ± 0.14B

0.87 ± 0.11B

1.11 ± 0.21B

< 0.001

Spleen (% of embryo weight)

0.06 ± 0.01A

0.11 ± 0.02B

0.13 ± 0.02B

0.08 ± 0.01A

0.11 ± 0.01B

0.08 ± 0.01A

0.10 ± 0.02B

< 0.001

  1. CON: Control group; Q10: Quercetin 10 ppm; Q100: Quercetin 100 ppm; HaP10: Hydroxyapatite 10 ppm; HaP100: Hydroxyapatite 100 ppm; QHaP10: Composite (quercetin + hydroxyapatite) 10 ppm; QHaP100: Composite (quercetin + hydroxyapatite) 100 ppm; Values are presented as mean ± SD. Different superscript letters within a row indicate statistically significant differences between groups (P < 0.01).